Efficacy and safety of duloxetine 60 mg once daily in major depressive disorder: a review with expert commentary.

Drugs Context · 2013 · PMC3884746 · PMID 24432034

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Response and remission rates, calculated using categorical MMRM analyses, were greater in the duloxetine group compared to the placebo group; however, the difference did not reach statistical significance (response: 49% vs 37%; remission 40% vs 28%).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.